Companies / Santa Cruz Biotechnology / ErbB-3 (RTJ.2) PE
Santa Cruz Biotechnology

ErbB-3 (RTJ.2) PE | Santa Cruz Biotechnology

mouse monoclonal IgG1; ErbB3/HER3 Antibody (RTJ.2) is an IgG1 κ mouse monoclonal ErbB-3 antibody (also designated ErbB-3 antibody) that detects ErbB-3 of mouse, rat and human origin by WB, IP, IF, IHC(P) and FCM. ErbB3/HER3 Antibody (RTJ.2) is available as the non-conjugated anti-ErbB-3 antibody form, as well as multiple conjugated forms of anti-ErbB-3 antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. The EGF receptor family comprises several related receptor tyrosine kinases that are frequently overexpressed in a variety of carcinomas. Members of this receptor family include EGFR (HER1), Neu (ErbB-2, HER2), ErbB-3 (HER3) and ErbB-4 (HER4), which form either homodimers or heterodimers upon ligand binding. Full length ErbB-3 is overexpressed in human mammary tumors. The ErbB-3 gene also produces several alternative variants, including a secreted form of which negatively regulates heregulin stimulated ErbB activation. ErbB-3 heterodimerizes with Neu and binds heregulin in order to activate phosphoinositide (PI) 3-kinase. The recruitment and activation of PI 3-kinase occurs via its interaction with phosphorylated YXXM motifs in the carboxy terminus of ErbB-3.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.